Abstract RNA technology, most prominently messenger RNA (mRNA), has transformed vaccine development by enabling rapid, sequence-specific antigen design, scalable manufacturing, and transient protein expression. Its long-term significance, however, extends beyond prophylactic vaccination. This Perspective argues that mRNA should be conceptualised as a programmable therapeutic platform capable of integrating vaccination, immune modulation, and on-demand disease treatment.
